Cardiac hypertrophy at autopsy

被引:0
|
作者
Cristina Basso
Katarzyna Michaud
Giulia d’Amati
Jytte Banner
Joaquin Lucena
Kristopher Cunningham
Ornella Leone
Aryan Vink
Allard C. van der Wal
Mary N. Sheppard
机构
[1] University of Padua,Cardiovascular Pathology Unit, Department of Cardiac, Thoracic and Vascular Sciences and Public Health
[2] University Center of Legal Medicine Lausanne - Geneva,Department of Radiological, Oncological and Pathological Sciences
[3] Lausanne University Hospital and University of Lausanne,Department of Forensic Medicine
[4] Sapienza University of Rome,Forensic Pathology Service
[5] University of Copenhagen,Department of Laboratory Medicine and Pathobiology, Ontario Forensic Pathology Service
[6] Institute of Legal Medicine and Forensic Sciences,Cardiovascular and Cardiac Transplant Pathology Unit, Department of Pathology
[7] University of Toronto,Department of Cardiovascular Pathology, Cardiology Clinical Academic Group
[8] Sant’Orsola-Malpighi University Hospital,undefined
[9] University Medical Center Utrecht,undefined
[10] Utrecht University,undefined
[11] Amsterdam UMC,undefined
[12] Academic Medical Center,undefined
[13] Molecular and Clinical Sciences Research Institute,undefined
[14] St George’s Medical School,undefined
来源
Virchows Archiv | 2021年 / 479卷
关键词
Autopsy; Cardiovascular diseases; Diagnostic criteria; Hypertrophy; Quality in pathology;
D O I
暂无
中图分类号
学科分类号
摘要
Since cardiac hypertrophy may be considered a cause of death at autopsy, its assessment requires a uniform approach. Common terminology and methodology to measure the heart weight, size, and thickness as well as a systematic use of cut off values for normality by age, gender, and body weight and height are needed. For these reasons, recommendations have been written on behalf of the Association for European Cardiovascular Pathology. The diagnostic work up implies the search for pressure and volume overload conditions, compensatory hypertrophy, storage and infiltrative disorders, and cardiomyopathies. Although some gross morphologic features can point to a specific diagnosis, systematic histologic analysis, followed by possible immunostaining and transmission electron microscopy, is essential for a final diagnosis. If the autopsy is carried out in a general or forensic pathology service without expertise in cardiovascular pathology, the entire heart (or pictures) together with mapped histologic slides should be sent for a second opinion to a pathologist with such an expertise. Indication for postmortem genetic testing should be integrated into the multidisciplinary management of sudden cardiac death.
引用
收藏
页码:79 / 94
页数:15
相关论文
共 50 条
  • [31] Hippo and Cardiac Hypertrophy A Complex Interaction
    Windmueller, Rebecca
    Morrisey, Edward E.
    CIRCULATION RESEARCH, 2015, 117 (10) : 832 - 834
  • [32] Emerging therapeutic targets for cardiac hypertrophy
    Winkle, Alexander J.
    Nassal, Drew M.
    Shaheen, Rebecca
    Thomas, Evelyn
    Mohta, Shivangi
    Gratz, Daniel
    Weinberg, Seth H.
    Hund, Thomas J.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (01) : 29 - 40
  • [33] Signalling pathways in cardiac myocyte hypertrophy
    Sugden, PH
    ANNALS OF MEDICINE, 2001, 33 (09) : 611 - 622
  • [34] MOLECULAR MECHANISM OF CARDIAC-HYPERTROPHY
    KOMURO, I
    KURABAYASHI, M
    SHIBAZAKI, Y
    KATOH, Y
    HOH, E
    KAIDA, T
    IEKI, K
    TAKAKU, F
    YAZAKI, Y
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1990, 54 (05): : 526 - 534
  • [35] Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy
    Gallicano, G. Ian
    Fu, Jiayu
    Mahapatra, Samiksha
    Sharma, Michael V. R.
    Dillon, Conor
    Deng, Claire
    Zahid, Maliha
    PHARMACEUTICALS, 2022, 15 (07)
  • [36] Bone Morphogenetic Protein-4 Mediates Cardiac Hypertrophy, Apoptosis, and Fibrosis in Experimentally Pathological Cardiac Hypertrophy
    Sun, Bo
    Huo, Rong
    Sheng, Yue
    Li, Yue
    Xie, Xin
    Chen, Chang
    Liu, Hui-Bin
    Li, Na
    Li, Cheng-Bo
    Guo, Wen-Ting
    Zhu, Jiu-Xin
    Yang, Bao-Feng
    Dong, De-Li
    HYPERTENSION, 2013, 61 (02) : 352 - +
  • [37] Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage
    Niu, P
    Shindo, T
    Iwata, H
    Iimuro, S
    Takeda, N
    Zhang, YL
    Ebihara, A
    Suematsu, Y
    Kangawa, K
    Hirata, Y
    Nagai, R
    CIRCULATION, 2004, 109 (14) : 1789 - 1794
  • [38] The mAKAP signalosorne and cardiac myocyte hypertrophy
    Bauman, Andrea L.
    Michel, Jennifer J. Carlisle
    Henson, Edward
    Dodge-Kafka, Kimberly L.
    Kapiloff, Michael S.
    IUBMB LIFE, 2007, 59 (03) : 163 - 169
  • [39] Sudden cardiac death with normal heart: molecular autopsy
    Basso, Cristina
    Carturan, Elisa
    Pilichou, Kalliopi
    Rizzo, Stefania
    Corrado, Domenico
    Thiene, Gaetano
    CARDIOVASCULAR PATHOLOGY, 2010, 19 (06) : 321 - 325
  • [40] Molecular autopsy in Chinese sudden cardiac death in the young
    Kwok, Sit-Yee
    Ho, Stephanie
    Shih, Fong-Ying
    Yeung, Pak-Kwan
    Cheng, Shirley S. W.
    Poon, Wai-Ming
    Lo, Ivan F. M.
    Luk, Ho-Ming
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2024, 194 (11)